Genomic Drug Discovery Startup Warp Drive Launches with $125M from Sanofi, Other Backers | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warp Drive Bio, a new firm that plans to apply a "genomic search engine" to identify new drugs in microbes, kicked off today with $125 million in initial financing from Sanofi, Third Rock Ventures, and Greylock Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.